Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
(2016) In European Journal of Endocrinology 174(1). p.17-24- Abstract
- The role of cabergoline in Cushing's disease (CD) remains controversial. The experience is limited to case reports and few open studies that report the effects determined after ≥1 month of treatment. In prolactinomas and dopamine-responsive GH-secreting tumours, effects of cabergoline are seen within days or weeks. Here, we searched for short-term effects of cabergoline in CD.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8235179
- author
- Burman, Pia LU ; Edén-Engström, Britt ; Ekman, Bertil ; Karlsson, F Anders ; Schwarcz, Erik and Wahlberg, Jeanette
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Endocrinology
- volume
- 174
- issue
- 1
- pages
- 17 - 24
- publisher
- Society of the European Journal of Endocrinology
- external identifiers
-
- pmid:26582653
- wos:000366401700007
- scopus:84956820858
- pmid:26582653
- ISSN
- 1479-683X
- DOI
- 10.1530/EJE-15-0807
- language
- English
- LU publication?
- yes
- id
- a4fbd21b-71b6-470b-9c5c-eefc99a67e32 (old id 8235179)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26582653?dopt=Abstract
- date added to LUP
- 2016-04-01 10:41:52
- date last changed
- 2025-04-04 15:19:32
@article{a4fbd21b-71b6-470b-9c5c-eefc99a67e32, abstract = {{The role of cabergoline in Cushing's disease (CD) remains controversial. The experience is limited to case reports and few open studies that report the effects determined after ≥1 month of treatment. In prolactinomas and dopamine-responsive GH-secreting tumours, effects of cabergoline are seen within days or weeks. Here, we searched for short-term effects of cabergoline in CD.}}, author = {{Burman, Pia and Edén-Engström, Britt and Ekman, Bertil and Karlsson, F Anders and Schwarcz, Erik and Wahlberg, Jeanette}}, issn = {{1479-683X}}, language = {{eng}}, number = {{1}}, pages = {{17--24}}, publisher = {{Society of the European Journal of Endocrinology}}, series = {{European Journal of Endocrinology}}, title = {{Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.}}, url = {{http://dx.doi.org/10.1530/EJE-15-0807}}, doi = {{10.1530/EJE-15-0807}}, volume = {{174}}, year = {{2016}}, }